Visiongain

Visiongain’s latest report “Mobile Payment: Operator Strategies, Opportunities and Challenges 2011” examines and analyses the developments in the emerging mobile payments sector, providing forecasts of growth for the key markets from 2011-2016.

The Industrial & Bulk Packaging Market 2011-2021 examines the scope of growth available in this dynamic packaging industry. Visiongain's has concluded that the global value of the industrial & bulk packaging market will reach $134.9bn in 2011.

A new report by Visiongain predicts that world asthma and COPD drug revenues will reach $43.8bn in 2015. That market generated $32.1bn in 2010, according to Asthma and COPD Therapies: World Market 2011-2021, published in August 2011.

Visiongain’s latest management research “Managed Services in LTE Era Report 2011-2016” examines the market for managed services, with particular reference to the Long Term Evolution (LTE) boom.

Visiongain’s latest report 'Moving into the Realm of an Essential IT Strategy' examines the fast-growing cloud services market. The research shows that more than 30% of enterprises worldwide are deploying at least one cloud solution.

Visiongain's lastest energy report - The Oil Sands Market 2011-2021 - examines the rapid expansion in the oil sand industry with in-depth analysis of global, regional and select national markets.

A new report by London-based business information company visiongain, predicts that world pre-filled syringe technology revenues will reach $3.9bn in 2015. That devices market generated $2.7bn (for the technology itself) in 2010.

. A new report by visiongain, a London-based business information company, predicts that world regenerative medicine revenues will reach $8.84bn in 2021. That market generated $0.82bn in 2010.

Visiongain’s latest management report “Huawei Report 2011: Securing New Markets and Gaining Competitive Advantage in the LTE Domain” examines the Chinese telecom technology company Huawei, with references to its involvement in the LTE boom.

A new report by visiongain, a London-based business information provider, predicts that the global biomarkers market will be worth $19.86bn in 2015. The market generated $14.18bn in 2010.